SerpinPC
Sponsors
Apcintex Limited, ApcinteX Ltd
Conditions
Hemophilia BHemophilia B with InhibitorHemophilia aHemophilia a with InhibitorSevere Hemophilia A or Moderately Severe to Severe Hemophilia B
Phase 1
Phase 2
A Study of SerpinPC in Participants with Hemophilia B (HemB) with Inhibitors
TerminatedNCT05789537
Start: 2023-07-28End: 2025-02-24Updated: 2025-03-11
The Efficacy and Safety of SerpinPC in Participants with Severe Hemophilia a or Moderately Severe to Severe Hemophilia B
TerminatedNCT05789524
Start: 2023-07-06End: 2025-02-28Updated: 2025-03-11
A Global, Open-label, Adaptive Design Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B (PRESent-2)
CompletedCTIS2022-502880-39-00
Start: 2023-11-13End: 2025-01-16Target: 59Updated: 2024-10-21
A Global, Open-label Study to Investigate the Efficacy and Safety of SerpinPC in Subjects With Hemophilia B With Inhibitors (PRESent-3)
CompletedCTIS2022-502881-25-00
Start: 2023-11-16End: 2024-11-12Target: 6Updated: 2024-08-06